Abiopharma

🔍 Snow John Ingalls III (Director)

Company: Winchester Bancorp, Inc./MD/ (WSBK)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 1,525 shares of Common Stock at $12.79 per share (Direct)
  Date: 2026-05-07 | Code: P | equity_swap_involved: 0 | shares_owned_after: 19,535.00 | transaction_form_type: 4
• Acquired 200 shares of Common Stock at $12.77 per share (Direct)
  Date: 2026-05-07 | Code: P | equity_swap_involved: 0 | shares_owned_after: 19,735.00 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: H | nature_of_ownership: By Child | shares_owned_after: 200.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: H | nature_of_ownership: By Company | shares_owned_after: 2,500.00